Clinical testing for oncology and rare diseases is one of the most promising fields of translational scientific research. As we move into an era of subtype and stratified disease phenotypes, clinical diagnostics companies will lead the way in helping to shape the community conversation between basic research, drug development, healthcare providers and patients. They must help shape the conversation around integration and analysis of vast, multi-modal datasets, particularly around AI and machine learning while trying to ensure balanced training data and patient privacy. This webinar explores these challenges and highlight strategies to drive innovation in oncology and rare disease.

Please fill out the form to access the on-demand recording.